---
figid: PMC3044050__zh40021196950006
figlink: /pmc/articles/PMC3044050/figure/F6/
number: Fig. 6
caption: Spry2 and Spry2Y55F function in the context of EC MAPK signaling. Upon growth
  factor (GF) binding to its respective receptor tyrosine kinase (RTK) and activation
  of the respective signaling pathway, Spry2 is induced to translocate to the inner
  plasma membrane where it gets activated (in many cases via phosphorylation on the
  Y55 by a Src-like kinase) and functions by interacting with various MAPK signaling
  pathway-associated proteins in a GF-specific manner. When RTK signaling is Ras dependent
  (left), Spry2 inhibition of this pathway is thought to occur at the level of GF
  receptor-bound protein-2 (Grb2) or Raf1. When RTK signaling is Ras independent (right),
  Spry2 inhibition of this pathway is thought to occur at the level of Raf1. In many
  cases, pY55 is required for Spry2 inhibition of the Raf/Mek/Erk pathway. The dominant-negative
  Y55F mutant of Spry2 inhibits endogenous Spry2 action, thereby promoting the Raf/Mek/Erk
  pathway. FGF-2, fibroblast GF-2; PDGF, platelet-derived GF; pY, phosphorylated tyrosine;
  Sos1, son of sevenless-1; PLC-γ, phospholipase C-γ; PIP2, phosphatidylinositol bisphosphate;
  DAG, diacylglycerol; IP3, inositol trisphosphate; PKC, protein kinase C. Information
  in this figure was compiled from Refs. , , , , , , , , .
pmcid: PMC3044050
papertitle: Sprouty2 downregulates angiogenesis during mouse skin wound healing.
reftext: Mateusz S. Wietecha, et al. Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H459-H467.
pmc_ranked_result_index: '50847'
pathway_score: 0.9298304
filename: zh40021196950006.jpg
figtitle: Spry2 and Spry2Y55F function in the context of EC MAPK signaling
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3044050__zh40021196950006.html
  '@type': Dataset
  description: Spry2 and Spry2Y55F function in the context of EC MAPK signaling. Upon
    growth factor (GF) binding to its respective receptor tyrosine kinase (RTK) and
    activation of the respective signaling pathway, Spry2 is induced to translocate
    to the inner plasma membrane where it gets activated (in many cases via phosphorylation
    on the Y55 by a Src-like kinase) and functions by interacting with various MAPK
    signaling pathway-associated proteins in a GF-specific manner. When RTK signaling
    is Ras dependent (left), Spry2 inhibition of this pathway is thought to occur
    at the level of GF receptor-bound protein-2 (Grb2) or Raf1. When RTK signaling
    is Ras independent (right), Spry2 inhibition of this pathway is thought to occur
    at the level of Raf1. In many cases, pY55 is required for Spry2 inhibition of
    the Raf/Mek/Erk pathway. The dominant-negative Y55F mutant of Spry2 inhibits endogenous
    Spry2 action, thereby promoting the Raf/Mek/Erk pathway. FGF-2, fibroblast GF-2;
    PDGF, platelet-derived GF; pY, phosphorylated tyrosine; Sos1, son of sevenless-1;
    PLC-γ, phospholipase C-γ; PIP2, phosphatidylinositol bisphosphate; DAG, diacylglycerol;
    IP3, inositol trisphosphate; PKC, protein kinase C. Information in this figure
    was compiled from Refs. , , , , , , , , .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCD
  - PDGFD
  - VEGFB
  - FGF2
  - VEGFD
  - PDGFA
  - PRKCI
  - PGF
  - GRB2
  - PLCG2
  - RAF1
  - VEGFC
  - SOS1
  - PRKCQ
  - VEGFA
  - MAPK3
  - PDGFB
  - NRAS
  - PRKCZ
  - PRKCE
  - PLCG1
  - PRKCG
  - MAP2K2
  - MAPK1
  - HRAS
  - PDGFC
  - KRAS
  - PRKD3
  - SPRY2
  - PRKCA
  - PRKCH
  - PRKCB
  - MAP2K1
  - Cancer
  - Noonan syndrome
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: GFFGF-2,PDGF,VEGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: GFFGF-2,PDGF,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: FGF-2,
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: GFFGF-2,PDGF,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: GFFGF-2,PDGF,VEGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: GFFGF-2,PDGF,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: Raf1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: GFFGF-2,PDGF,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Sos1
  symbol: SOS1
  source: hgnc_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: GFFGF-2,PDGF,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GFFGF-2,PDGF,VEGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Mek1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: GFFGF-2,PDGF,VEGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Spry2
  symbol: SPRY2
  source: hgnc_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: Mek1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
